// App-Quantinova.ai

[AB1193] : USAGE PATTERN OF CONCOMITANT THERAPY WITH BIOLOGICAL DMARDS IN CHINESE PATIENTS WITH RHEUMATOID ARTHRITIS: A MULTI-CENTER CROSS-SECTIONAL STUDY

Researchers

Presenter

  • T. Liu

Principal Investigators

  • Y. An

  • Z. Li

  • X. Liu

  • X. Li

  • N. Yang

  • Z. Zhang

  • H. Song

  • W. Wei

  • J. Liu

  • D. He

  • L. Wu

  • J. Li

  • Y. Liu

  • L. Bi

  • B. Zhou

  • C. Lin

  • L. He

Medical Centers

  • Peking University People's Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methylprednisolone

  • Loxoprofen

  • Glucocorticoid

  • Sulfasalazine

  • Methotrexate

  • HWA-486

  • Ketoprofen

  • Diclofenac

  • Prednisone

  • Celecoxib

  • ALT-210

  • Meloxicam

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved